Does risk-reducing removal of the ovaries and tubes treat BRCA gene mutation?

BRCA1 and BRCA2 are inherited gene changes that can increase the chance of developing breast, ovarian, fallopian-tube and related cancers. Surgery removes organs where some of these cancers can begin, so it changes future cancer risk rather than changing the DNA present in your cells. It cannot remove BRCA-related risk in other organs, and it does not replace breast screening or a personalised prevention plan. After the operation, menopause may begin if the ovaries were still producing hormones.

Discuss your test result and family history with a genetic counsellor and a gynaecological oncology team. They can explain timing, fertility implications, hormone symptoms, surgical recovery and whether hormone treatment is suitable. Ask which breast imaging and clinical checks remain appropriate, and tell the team about medicines, previous operations and plans for pregnancy before deciding.

Seek urgent medical help for severe abdominal pain, fainting, heavy bleeding, chest pain, sudden breathlessness or a fever after surgery. Contact the surgical team promptly for worsening wound redness, swelling, drainage, vomiting or pain that is not controlled by the agreed medicines.

Which BRCA-related risks does this operation address? What screening remains afterward? How could it affect fertility, hormones, bones and heart health? Would genetic counselling or testing be useful for relatives?